The National Imaging Facility has announced the appointment of Professor Karen Jones to its independent Governing Board.

The independent Governing Board provides oversight and strategic guidance for all NIF activities and investments, supporting NIF’s objective to address Australia’s strategic science and research priorities, benefit Australian industry and help keep Australians healthy.

Prof Jones brings a wealth of expertise in human imaging and nuclear medicine, with a distinguished career marked by pioneering research in the fields of gastric emptying and postprandial hypotension.

Leadership roles, including President of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM) and former Chair of both the ANZSNM Technologist Special Interest Group (TSIG) and Executive Committee of the Australasian Radiopharmaceutical Trials Network (ARTnet), underscore Prof Jones’ advocacy for nuclear medicine technologists and commitment to excellence in the field of nuclear medicine.

NIF Governing Board Chair Professor Margaret Harding congratulated Prof Jones on her appointment.

“Prof Jones’ contributions will greatly enhance our mission to enable significant impacts on national health challenges and accelerate Australian innovation,” Prof Harding said.

Read more about NIF’s independent Governing Board here.

About Professor Karen Jones
Prof Karen Jones is a distinguished leader in medical imaging, with a stellar academic and research background. Prof Jones was the first nuclear medicine technologist in Australia to complete a PhD and is a champion of her field. As President of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM) and former Chair of both the ANZSNM Technologist Special Interest Group (TSIG) and Executive Committee of the Australasian Radiopharmaceutical Trials Network (ARTnet), she has significantly influenced the profession. Her pioneering research on gastric emptying and postprandial hypotension, utilising advanced imaging techniques, has set new standards in the field. Prof Jones’ strategic vision and leadership continue to drive innovation and excellence in nuclear medicine, benefiting both the scientific community and clinical practice.